Treatment with ropeginterferon alfa-2b in patients with hydroxyurea resistant or intolerant polycythemia vera in South Korea: one-year results from a phase 2 study.

Blood Res

Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpodae-ro, Seocho-Gu, Seoul, 06591, Korea.

Published: July 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11233476PMC
http://dx.doi.org/10.1007/s44313-024-00026-6DOI Listing

Publication Analysis

Top Keywords

treatment ropeginterferon
4
ropeginterferon alfa-2b
4
alfa-2b patients
4
patients hydroxyurea
4
hydroxyurea resistant
4
resistant intolerant
4
intolerant polycythemia
4
polycythemia vera
4
vera south
4
south korea
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!